Extracellular vesicles (EVs) carry signals within or at their limiting membranes, providing a mechanism by which cells can exchange more complex information than what was previously thought. In addition to mRNAs and microRNAs, there are DNA fragments in EVs. Solexa sequencing indicated the presence of at least 16434 genomic DNA (gDNA) fragments in the EVs from human plasma. Immunofluorescence study showed direct evidence that acridine orange-stained EV DNAs could be transferred into the cells and localize to and inside the nuclear membrane. However, whether the transferred EV DNAs are functional or not is not clear. We found that EV gDNAs could be homologously or heterologously transferred from donor cells to recipient cells, and increase gDNA-coding mRNA, protein expression, and function (e.g. AT 1 receptor). An endogenous promoter of the AT 1 receptor, NF-kB, could be recruited to the transferred DNAs in the nucleus, and increase the transcription of AT 1 receptor in the recipient cells. Moreover, the transferred EV gDNAs have pathophysiological significance. BCR/ABL hybrid gene, involved in the pathogenesis of chronic myeloid leukemia, could be transferred from K562 EVs to HEK293 cells or neutrophils. Our present study shows that the gDNAs transferred from EVs to cells have physiological significance, not only to increase the gDNA-coding mRNA and protein levels, but also to influence function in recipient cells.
Introduction
Cell-to-cell communication is required to guarantee proper coordination among different cell types within tissues. There are multiple types of intercellular communication, including soluble factors, tunneling nanotubules, and extracellular vesicles (EVs), which allow the transfer of surface molecules or cytoplasmic components from one cell to another. EVs are circular plasma membrane fragments that include exosomes and microparticles or shed vesicles (Trajkovic et al., 2008; Thery et al., 2009) . The biological function of EVs is poorly understood, but may include secretion, immunomodulation, coagulation, and intercellular communication (Cocucci et al., 2009; Pap et al., 2009; Wang et al., 2012) .
EVs may vary in their abundance, size, and composition, but they often contain materials, which include functional transmembrane proteins, mRNAs, and microRNAs (Valadi et al., 2007; Skog et al., 2008; Gibbings et al., 2009; Zen and Zhang, 2012) . The components in EVs could be transferred from one cell to another by endocytosis or fusion with the recipient cell (Denzer et al., 2000; Clayton et al., 2004; Morelli et al., 2004; Ogawa et al., 2010) . Moreover, the transferred components in EVs are functional. For example, glioblastoma EVs are enriched in angiogenic proteins, which stimulate tubule formation in endothelial cells (Skog et al., 2008) . Besides functional proteins, Valadi et al. (2007) reported the presence of mRNA from 1300 genes, many of which are not present in the cytoplasm of the donor cell. The packaged mRNAs or microRNAs in EVs could be delivered to target cells that can modulate the biological functions of these cells by promoting or repressing target gene expression (Valadi et al., 2007; Al-Nedawi et al., 2008; Skog et al., 2008; Zhang et al., 2010) .
Recent studies have shown that both mitochondrial DNA (mtDNA) and chromosomal DNA were found in EVs (Guescini et al., 2010; Balaj et al., 2011; Waldenstrom et al., 2012) . Waldenstrom et al. (2012) reported that chromosomal DNA sequences in EVs from cardiomyocytes could be transferred to the cytosol or nuclei of target cells. However, whether the transferred EV DNAs are functional or not is unclear. In this study, we investigated the function and potential mechanisms of transferrable EV DNAs in the recipient cells. We first examined the existence of genomic DNA (gDNA) in EVs derived from human plasma and supernatants of vascular smooth muscle cells (VSMCs) in culture by Solexa sequencing and PCR.
Angiotensin II type 1 (AT 1 ) receptors exist ubiquitously and mediate several functions, including vasoconstriction, vascular proliferation, and renal antinatriuresis (Klingbeil et al., 2000; Zhang et al., 2005) . Abnormal expression and activation of AT 1 receptors are associated with cardiovascular diseases (e.g. hypertension and atherosclerosis). To determine the transportability and functionality of the DNA fragments in EVs, we studied the transport of gDNAs (AT 1 receptor DNA) in EVs from AT 1 receptor transfected HEK293 cells or VSMCs to non-transfected HEK293 cells. To uncover the underlying mechanisms leading to the transcription of transferred EV DNA, we investigated the effect of endogenous NF-kB, a promoter of the AT 1 receptor gene, on transferred DNAs including AT 1 receptor DNA.
Previous studies have shown an increased quantity of EVs in the body fluids of patients with cancer and provided increasing evidence that EVs might play a pivotal role in tumorigenesis (Skog et al., 2008; Balaj et al., 2011) . Chronic myeloid leukemia (CML) is a clonal myeloproliferative disease, characterized by the oncogenic Philadelphia chromosome, which is formed by a reciprocal translocation between chromosomes 9 and 22 (Pluk et al., 2002) . This translocation causes 50 portions of the breakpoint cluster region (BCR) gene from chromosome 22 to juxtapose with the 30 tyrosine kinase domains of the v-abl Abelson murine leukemia viral oncogene (ABL) from chromosome 9 (Pluk et al., 2002) . The newly encoded chimeric protein BCR/ABL dictates the pathophysiology of CML and is recognized as the main target for tyrosine kinase inhibitors, such as imatinib, to treat CML patients (Pluk et al., 2002; Shibata et al., 2010; Puissant et al., 2012) . To determine the pathophysiological significance of transferred gDNAs in EVs between cells, we examined the transfer of BCR/ABL hybrid gene in EVs from K562 cells to normal human neutrophils isolated from human peripheral blood.
Results

Isolation and identification of EVs
EVs from human plasma or cell culture supernatants were isolated through a series of ultracentrifugation steps as previously described (Valadi et al., 2007; Skog et al., 2008; Zhang et al., 2010) . To ensure that the EVs were correctly identified, electron microscopic, immunoblotting, and flow cytometry (FCM) analyses were used. The electron micrographs of the EVs revealed rounded EVs were fixed, with or without negative staining with Na-phosphotungstate, and observed by TEM. Regular EVs with different sizes from plasma (a and b) of normal human subjects and supernatants of VSMC cultures (negative staining, c and d) were observed under TEM. The sizes of the EVs are consistent with the size of shed vesicles (100 -1000 nm in size, red arrows) and exosomes (30-100 nm in size, green arrows). (B) FCM analysis. Samples, including VSMC EVs and VSMCs, were analyzed by BD Accuri C6 FCM. DMEM cell culture medium was used as negative control. The lower-left figure shows the overlay of the upper figures showing VSMC EVs in VSMCs (cells). (C) CD63, AGO2, TSG101, flotillin-1, and HSP70 expressions in EVs. EVs (1 × 10 7 /ml, 200 ml), isolated from plasma of normal human subjects or VSMCs, were separated on SDS -PAGE, electroblotted onto nitrocellulose membrane, and subjected to immunoblotting with antibodies against CD63 (1:500), AGO2 Upper two images: DNA (6.27 ng/ml) in EVs from human plasma and VSMC supernatant was amplified by PCR using b-actin or D-loop primers, and the PCR products were analyzed on 2% agarose gel double-layer membranous vesicles of 30 -1000 nm in size, similar to previously described EVs (Valadi et al., 2007; Skog et al., 2008; Zhang et al., 2010 ; Figure 1A ). EVs more than 200 nm in size were confirmed by FCM analysis as this technology is unable to distinguish or enumerate single particles below 200 nm in size (Zwicker, 2010;  Figure 1B) . Immunoblotting showed the presence of CD63, argonaute 2 (AGO2), tumor susceptibility gene 101 (TSG101), flotillin-1, and heat shock protein 70 (HSP70) proteins, commonly used markers for EVs ( Figure 1C) .
Identification of DNA fragments in EVs
Substantial amounts of DNA were detected by fluorescenceactivated cell sorter (FACS), agarose gel electrophoresis, PCR, and Agilent 2100 Bioanalyzer (Agilent Technologies) in EVs derived from human plasma and supernatants of VSMCs in culture. The single-staining of EVs with acridine orange (AO) (membrane permeable) or DiI (a lipophilic dye) showed enhanced fluorescence, while single-staining of EVs with propidium iodide (PI) (membrane impermeable) had low fluorescence, similar to the unstained control EVs (Figure 2Aa ). Co-staining of EVs with AO and DiI showed an enhanced fluorescence compared with unstained (control) or single-stained EVs (Figure 2Ab ), suggesting that DNA is present only inside the thoroughly washed EVs. DNase (varying concentrations and periods of incubation) was incubated with EVs to further confirm that the DNA fragments were inside the EVs. DNase treated and non-treated control EVs (Figure 2Ba and b) showed the same electrophoretic pattern, arguing against DNA being present outside the EVs.
To show if the DNAs in EVs are double-strand (dsDNA) or singlestrand (ssDNA) DNA, we used SYBR Green I, which preferentially binds to dsDNA rather than ssDNA (Dragan et al., 2012) . Consistent with a previous report (Balaj et al., 2011) , we found that EVs contained dsDNA ( Figure 2C ). Agarose gel electrophoresis showed that EVs from both human plasma and supernatants of VSMCs in culture had DNA fragments ranging in size from 1 to 20 kb, but mostly around 17 kb (Figure 2Ba) . The bioanalyzer study found that the sizes of the DNA fragments within EVs ranged from 6 to 17 kb, and the DNA content in EVs from 30 ml plasma was about 300 ng (6.27 ng/ml × 50 ml; Figure 2D ). Consistent with other reports (Guescini et al., 2010) , after amplification of DNA fragments in EVs with specific primers, PCR showed the presence of b-actin DNA and mtDNA, D-Loop, in EVs ( Figure 2E ). The existence of b-actin and D-loop fragments in EVs was confirmed by sequencing ( Figure 2E) ; the percentage identity of the sequences was more than 99.5% for each fragment. After the disrupted EVs were treated with DNase, the EV DNAs were degraded, further supporting the location of EV DNAs inside the EVs ( Figure 2E ). To determine whether or not the EVs are from apoptotic cells, we checked the presence of apoptosis in VSMCs by PI which is excluded by living but not by dead or dying cells; there was low fluorescence in VSMCs, excluding apoptosis as a source of DNA ( Figure 2F ). Solexa sequencing found at least 16434 gene fragments in the EVs from human plasma, including the AT 1 receptor gene ( Table 1) . Transportable and functional AT 1 receptor DNA in EVs target HEK293 cells
To determine the transportability and functionality of the DNA fragments in EVs, we used EVs from AT 1 receptor transfected HEK293 (AT 1 -HEK293) cells to treat non-transfected HEK293 cells. To exclude the interference of endogenous AT 1 receptor DNA, we transfected the HEK293 cells with AT 1 -EGFP (enhanced green fluorescent protein, EGFP) so that AT 1 -HEK293 cells as well as their EVs bore AT 1 -EGFP DNA. Therefore, the AT 1 -EGFP DNA in recipient cells unequivocally distinguishes the endogenous AT 1 receptor from the exogenous (i.e. transferred) one. We found AT 1 -EGFP DNA in EVs from AT 1 -HEK293 cells but not in EVs from untransfected HEK293 cells ( Figure 3A) . The presence of AT 1 -EGFP DNA in AT 1 -HEK293 EVs was confirmed by sequencing, and the percentage sequence identity was more than 99.5% ( Figure 3A) . Incubation of HEK293 cells with EVs from AT 1 -HEK293 cells (1 × 10 5 /ml for 24 h) increased the AT 1 receptor mRNA ( Figure 3B . AT 1 receptor protein expression was determined by immunoblotting (n ¼ 3, *P , 0.05 vs. others). (D) Confocal microscopy images of HEK293 cells cultured with EVs co-stained with AO and DiI. (a) After culturing HEK293 cells with VSMC EVs co-stained with DiI (a lipophilic dye, red) and AO (a DNA dye, green) for 24 h at 378C, the HEK293 cells were observed by confocal microscopy. The transferred EVs localized inside the cell (red) and transferred DNA inside the cell (green) and nuclei (cyan, green arrows) in HEK293 cells incubated with the VSMC EVs. Yellow fluorescence shows co-localization (yellow arrows) of membrane of EVs (DiI, red) and transferred DNA (AO, green). (b) After culturing HEK293 cells with AO-stained EVs from VSMC cells for 24 h at 378C, HEK293 cells were observed by confocal microscopy, in which NF-kB was stained. White fluorescence shows co-localization (white arrow) of nuclei (DAPI-staining, blue), transferred DNA (AO-staining, green), and NF-kB (Cy3-staining, red).
cells. In the presence of actinomycin D (5.0 mg/ml), an inhibitor of de novo mRNA synthesis, the stimulatory effect of EVs from AT 1 -HEK293 cells on co-incubated HEK293 cells was blocked, indicating that there was de novo AT 1 receptor mRNA synthesis in the HEK293 cells incubated with EVs from AT 1 -HEK293 cells ( Figure 3B and Cb). To further elucidate the underlying mechanisms, we used laser confocal microscopy, and found that DNA (green with AO staining) in EVs (red with the DiI lipophilic dye) (co-localization ¼ yellow), could be transferred into the cells and localize to and inside the nuclear membrane (Figure 3Da) . We checked the association between endogenous NF-kB, as a promoter of AT 1 receptor gene, and transferred DNAs including AT 1 receptor DNA. Results showed that endogenous NF-kB could be recruited to the transferred DNAs in the nucleus (Figure 3Db) , indicating that the transcription of transferred AT 1 receptor gene occurs in the recipient cells.
In addition to the studies on the transfer of gDNA in EVs between same originated cell lines (e.g. AT 1 -HEK293 and HEK293), we also studied the transport of gDNAs in EVs between different cell lines (VSMC and HEK293). We found, by PCR, the presence of AT 1 receptor gene coding region, 5 ′ promoter region, and 3 ′ untranslated region in EVs from VSMCs ( Figure 4A ). The presence of the three regions of the AT 1 receptor gene in VSMC EVs was confirmed by sequencing, and the percentage sequence identity was more than 99.5% for each fragment ( Figure 4A ). We also found that EVs from VSMCs increased AT 1 receptor protein expression in HEK293 cells in a concentration-(0.25 × 10 5 -2.0 × 10 5 /ml) and time (6-48 h)-dependent manner ( Figure 4B and C), and also increased AT 1 receptor mRNA levels in HEK293 recipient cells ( Figure 4D ). The transportable AT 1 receptor was functional because treatment of HEK293 cells with VSMC EVs (1 × 10 5 /ml) for 24 h increased the stimulatory effect of angiotensin II (1 × 10 26 M for 30 min)
on Na + -K + ATPase activity ( Figure 4E ), an effect that was blocked by losartan (1 × 10 26 M), an AT 1 receptor blocker ( Figure 4F ). In contrast, in HEK293 cells treated with its own EVs, the stimulatory effect of angiotensin II on Na + -K + ATPase activity was not affected ( Figure 4E ).
Transportable and functional BCR/ABL hybrid gene in EVs from K562 cells to HEK293 cells or neutrophils
The VSMC and HEK293 studies only provided indirect evidence that the increased AT 1 mRNA is due to the incorporation of DNA from EVs. To overcome this limitation, we studied the transport of the BCR/ABL hybrid gene, which is not normally expressed in HEK293 cells. PCR showed that the BCR/ABL hybrid gene is present in the EVs from K562 cells, but not from HEK293 cells, suggesting that the presence of BCR/ABL hybrid gene is unique for K562 cells ( Figure 5A ). Incubating HEK293 cells with EVs (1 × 10 5 /ml) from K562 cells for 24 h resulted in the expression of BCR/ABL hybrid gene mRNA and protein in the recipient HEK293 cells (Figure 5Ba and b) . The heterologous expression of BCR/ ABL hybrid gene mRNA and protein in the HEK293 cells incubated with K562 EVs was prevented by the concurrent incubation with actinomycin D (5 mg/ml; Figure 5Ba and c) .
To determine the pathophysiological significance of transferred gDNAs in EVs between cells, we investigated the effect of BCR/ ABL hybrid gene in EVs transferred from K562 cells to normal human neutrophils isolated from human peripheral blood. Using a BCR/ABL D-FISH (dual-fluorescence in situ hybridization) method, we found that normal neutrophils did not contain the BCR/ABL hybrid gene. However, incubation of normal human neutrophils with EVs (1 × 10 5 /ml) from K562 cells for 24 h resulted in the expression of BCR/ABL hybrid gene in 20% of the neutrophils ( Figure 5C ).
Discussion
EVs can carry signals within or at their limiting membrane, providing a mechanism by which cells can exchange more complex information than what was previously thought (Trajkovic et al., 2008; Thery et al., 2009 ). The packaged mRNAs or microRNAs in EVs can be delivered into target cells, and modulate the biological functions of these cells by gene-regulated promotion or repression of target gene expression (Skog et al., 2008; Cocucci et al., 2009; Pap et al., 2009) . In the present study, we found that in addition to mRNA, microRNA, and protein, EVs contain numerous gDNA fragments. These gDNAs in EVs are transportable between the same or different types of cells, increase the gDNA-coding mRNA and protein expressions in the recipient cells, and have physiological significance to influence function in recipient cells. In this study, the AT 1 receptor DNA in EVs could increase AT 1 receptor expression and AT 1 receptorstimulated Na + -K + ATPase activity in recipient HEK293 cells.
The underlying mechanisms are not completely clear, or at least, could not be explained by the existence of mRNA in the EVs, because the level of AT 1 mRNA in EVs is much lower than the increased AT 1 receptor mRNA level in the recipient cells (data not shown). Moreover, actinomycin D, an inhibitor of DNA transcription, blocks the stimulatory effect of EVs from the donor cells on AT 1 receptor mRNA expression in the recipient HEK293 cells, indicating that the transcription of DNAs from the EVs occurs in the recipient cells. It is known that for a DNA fragment to have the potential for expression it should, apart from the open reading frame, include regulatory 5 ′ and 3 ′ elements necessary for the recruitment and proper function of the cellular machinery involved in transcription (Balaj et al., 2011) . Our current study found and confirmed the presence of AT 1 receptor gene coding region, 5 ′ promoter region, and 3 ′ untranslated region in EVs from VSMC cells.
The view that DNAs in EVs could be transferred into the recipient cells and localize to and inside the nuclear membrane is supported by the previous study (Waldenstrom et al., 2012) . Our present study provides direct evidence that transferred gene can be transcribed in the recipient cells. Owing to the presence of endogenous AT 1 receptor DNA in the HEK293 cells, it is possible that the endogenous DNA was activated by the EVs, causing the increase in AT 1 receptor mRNA and protein expressions in HEK293 recipient cells. To overcome this limitation, we treated the HEK293 cells with EVs bearing AT 1 -EGFP DNA derived from AT 1 -HEK293 cells, by which the endogenous AT 1 receptor can be distinguished from exogenous (i.e. transferred) AT 1 -EGFP DNA transcribed receptor. Moreover, we chose the BCR/ABL hybrid gene, which is unique in a CML cell line K562 but not endogenously present in the HEK293 cells or neutrophils. By this study, we provided further direct evidence that EV gDNAs can be transferred to and expressed in recipient cells. ′ promoter region, and 3 ′ untranslated region in EVs were detected by PCR, and the PCR products were analyzed on 2% agarose gel precasted with ethidium bromide. DNA marker (lane M), VSMC EVs (lanes 1, 4, and 7), VSMC cells (lanes 2, 5, and 8), negative control (ddH 2 O, lanes 3, 6, and 9). Lanes 1 -3, lanes 4-6, and lanes 7-9 show AT 1 receptor gene coding region, CML is characterized by a reciprocal translocation between chromosomes 9 and 22, which encodes the chimeric tyrosine kinase BCR/ABL that is responsible to affect malignant cell behavior and pathophysiology, and thus a therapeutic target of CML (Pluk et al., 2002; Shibata et al., 2010; Puissant et al., 2012) . Although the detailed actions of EVs in CML are not clear, our present study found that incubation of K562 EVs with normal neutrophils makes them express BCR/ABL, indicating a possible role of EVs in tumorigenesis.
Gene therapy has an enormous potential to treat genetic diseases. Two types of vectors, viruses and liposomes, have been used in clinical and research work (Wahlgren et al., 2012) . However, their side-effects, including toxicity and immunogenic concerns, hamper their use (Wahlgren et al., 2012) . Therefore, finding a biocompatible method to introduce exogenous gene into target cells becomes very urgent. Our findings in this study suggest that exogenous gene can be packaged into EVs of certain cells. Further, DNA-containing EVs can be delivered into target cells and these exogenous genes can alter the cellular functions of the recipient cells. EVs are proved to be safe and effective gene delivery tools (Cocucci et al., 2009; Wahlgren et al., 2012) . From this point of view, secreted DNA may represent a class of signaling molecules that may play an important role in mediating intercellular communication. Moreover, the selective secretion and targeting of DNA among different cells provide a highly regulated complex network under various physiological and pathophysiological conditions.
In conclusion, we have shown that EV DNAs, which could be delivered from one cell to another, can regulate the gDNA-coding mRNA and protein expressions in the recipient cells, and affect the physiological function in the recipient cells. EV-mediated transfer of gDNAs may represent a new method of gene delivery and novel way of signal transduction among cells. These findings would help in the discovery of novel mechanisms of disease and development of new therapeutic strategies.
Materials and methods
Blood collection
Blood was drawn from healthy donors at Daping Hospital (Chongqing, China), and stored in test tubes containing 3.8% trisodium citrate. Plasma was isolated by centrifugation at 1800× g for 15 min. All donors or their guardians provided signed informed consent forms, and the protocols for handling human blood and tissues were approved by the Ethics Committee of Daping Hospital.
Isolation of EVs
EVs were isolated from the plasma of healthy donors or cell culture supernatants by differential centrifugation according to previous reports (Valadi et al., 2007; Skog et al., 2008; Zhang et al., 2010) . When cells have grown to about 90% confluence, cell culture supernatants were collected. The plasma or cell culture supernatants were centrifuged at 500× g for 20 min, and the initial pellets were discarded to remove residual cells. Then, the supernatants were centrifuged again at 1500× g for 20 min and the pellets were also discarded to remove other debris. After re-centrifugation at 110000× g for 70 min, the final pellets containing the EVs were resuspended in fetal bovine serum-free medium (for cell EV) or phosphate-buffered saline (PBS) (for plasma EV). All steps were performed at 48C. The isolated EVs were then subjected to DNase I (20 Kunitz units/ml, Sigma-Aldrich Co.) digestion (30 min at 378C) to remove any DNA outside of the EVs. Ethylenediaminetetraacetic acid (EDTA) (10 mmol/L EVs) was then added to the EVs, and incubated for 5 min at 658C to inactivate any residual DNase. These EVs were used in the experiments.
Transmission electron microscopy
For negative-staining transmission electron microscopy (TEM), EVs were adsorbed to copper-coated mesh-grids for 2 min, and rinsed in filtered PBS. EVs on the grids were immediately fixed with 4% glutaraldehyde for 1 min and then negatively stained with 2% (wt/vol) Na-phosphotungstate for 1 min. Microscopic examinations were then carried out using Hitachi-7500 TEM (Hitachi, Ltd.), operated at 80 kV.
For conventional TEM, the EVs were placed in a droplet of 2.5% glutaraldehyde in PBS and fixed overnight at 48C. The samples were rinsed with PBS (10 min × 3) and fixed in 1% osmium tetroxide for 60 min at room temperature. The samples were then embedded in 10% gelatin, fixed in glutaraldehyde at 48C, and cut into several blocks (,1.0 mm 3 ). The samples were dehydrated with sequential increasing concentrations of alcohol (30%, 50%, 70%, 90%, 95%, and 100% × 3) for 10 min per step. Absolute alcohol was then finally changed to propylene oxide, and the specimens were exposed sequentially to increasing concentrations of Quetol-812 epoxy resin (25%, 50%, 75%, and 100%) mixed with propylene oxide for a minimum of 3 h per step. Samples were embedded in pure, fresh Quetol-812 epoxy resin and polymerized at 358C for 12 h, 458C for 12 h and 608C for 24 h. Ultrathin sections (100 nm) were cut using a Leica-UC6 ultra-microtome (Leica Co.) and post-stained with uranyl acetate for 10 min and then with lead citrate for 5 min at room temperature before observation by a Hitachi-7500 TEM, operated at 80 kV.
FCM analysis
The cell EVs and cells without pretreatment with latex beads were directly analyzed for the absolute counts using BD Accuri C6 FCM (Becton, Dickinson and Company; Bruno et al., 2009) . DMEM cell culture medium was used as negative control.
To evaluate whether DNAs are present inside or outside the EVs, FACS was used for analysis of DNA-stained EVs (Waldenstrom et al., 2012) . DNA dyes AO is membrane permeable, while PI is membrane impermeable and excluded from living cells. In addition, DiI (1,1
tetramethyl-indocarbocyanine perchlorate), a lipid membrane dye, was used for staining membranes of EVs (Trajkovic et al., 2008) . EVs (2 × 10 6 ) in 200 ml PBS were incubated with 10 ml AO (KeyGen Biotech) for 5 min, 10 ml PI (KeyGen Biotech) for 30 min, or 2 mM DiI (Beyotime Biotech) for 10 min dark at room temperature according to the manufacturer's recommendations. The AO-or PI-incubated EVs were ultracentrifuged, and washed twice with PBS. The same amounts of EVs and cells (about 100000 EVs or VSMCs) were analyzed by BD Accuri C6 FCM at the appropriate fluorescence emitting wavelengths (530 nm for AO, 565 nm for DiI, 670 nm for PI). For AO positive control, normal VSMCs (2 × 10 5 ) in 200 ml PBS incubated with AO were used, while for PI positive control, the same amount of VSMCs pretreated by freezing and thawing were used.
DNA extraction from EVs
The isolated EVs were subjected to DNase digestion to remove the DNA exterior to the EV, as described above. Total DNA was extracted from EVs with the TIANamp Genomic DNA Kit, following the manufacturer's recommendations (Tiangen Biotech Co. Ltd.). The quality and quantity of extracted DNA were measured by spectrophotometry (A260 nm) and electrophoresis on agarose gel precasted with ethidium bromide or SYBR Green I stain (dsDNA stain; Cai et al., 2011) .
The disruption of EVs was performed using TIANamp Genomic DNA Kit, following the manufacturer's recommendations, as aforementioned. EVs (2 × 10 6 ) in 200 ml PBS were lysed with proteinase K (2 mg/ml) and 200 ml lysis buffer and incubated at 708C for 10 min. Then the DNAs were precipitated with 200 ml ethanol and adsorbed with DNA-adsorbing column. Finally, EV DNAs were eluted with sterilized deionized water, followed by DNase I digestion.
Solexa sequencing
For Solexa sequencing, we used a DNA sample equally pooled from 30 independent samples extracted from plasma-derived EVs of healthy subjects. The characteristics of the human samples are listed in Table 2 . The sequencing procedure for DNA samples was mostly conducted as previously described for RNA samples (Chen et al., 2008; Zhang et al., 2010) , except of reverse transcription of RNA to cDNA. DNA samples were randomly fragmented from long to small DNA ( 200 bps). Then, the 5 ′ and 3 ′ ends of these small DNAs were repaired using end-repair enzyme, followed by adenylation of 3 ′ -ends, agarose gel purification, and ligation of a pair of Solexa adaptors to their 5 ′ and 3 ′ ends. The small DNA molecules were amplified using the adaptor primers for 17 cycles, and these fragments around 200 bp (small DNA + adaptors) were isolated from agarose gels. The purified DNAs were used directly for cluster generation and sequencing analysis using the Illumina Genome Analyzer (Illumina), according to the manufacturer's recommendations. The image files generated by the sequencer were then processed to produce digital-quality data. In these raw data, we removed adaptor sequences, poor quality reads, in which the number of base pairs with lower quality value (,5) was more than 50%, and contaminated reads, in which the percent of N was more than 5%. Finally, clean reads were processed for computational analysis, comparing them with the National Center for Biotechnology Information (NCBI) Reference Sequence project (RefSeq) database.
Laser confocal microscopy
To observe the transferred EV DNA to the recipient cells, VSMC-derived EVs (2 × 10 6 ) in 200 ml PBS were stained with AO and then washed with PBS, to eliminate contamination of unincorporated AO, as described previously. HEK293 cells were incubated with EVs, co-stained with AO and DiI, from VSMCs (1 × 10 5 /ml) for 24 h on a cell culture microscope slide (Nest Biotechnology Co. Ltd.; Waldenstrom et al., 2012) . DAPI (4,6-diamidino-2-phenylindole) was used to stain the nucleus. Localization of EVs, co-stained with AO and DiI, was determined by laser confocal microscopy.
To observe the co-localization of NF-kB with transferred EV DNA, HEK293 cells were incubated with AO-stained DNA EVs, as described above, in which nuclei were also stained with DAPI. NF-kB was stained using Cellular NF-kB Translocation Kit (Beyotime Biotech; Xu et al., 2008) . Nuclei (blue), transferred EV DNA (green), and NF-kB (red) were viewed through a Zeiss LSM 510 META laser confocal microscope (Carl Zeiss) at individual excitation wavelengths (350 nm for DAPI, 488 nm for AO, 540 nm for NF-kB, 549 nm for DiI). The co-localization of NF-kB, EV DNA, and nucleus appear white. Real-time PCR of DNA DNAs within EVs were amplified by real-time PCR, using SYBRw premix Ex Taq TM II according to the manufacturer's recommendations (TaKaRa Biotechnology Co. Ltd.). Twenty microliters of final reaction mixture contained 10 ml of Ex Taq, 0.8 ml of sense primer, 0.8 ml of antisense primer, 6.4 ml of sterile deionized water, and 2.0 ml of DNA extract. Thermocycling was conducted using a CFX96 TM Real-Time PCR Detection System (Bio-Rad Laboratories Inc.) initiated by a 30 sec incubation at 958C, followed by 40 cycles at 948C for 5 sec and 608C for 45 sec with a single fluorescent reading taken at the end of each cycle. Each reaction was conducted in triplicate. All the runs were completed with a melt curve analysis to confirm the specificity of amplification and lack of primer dimers. PCR products were analyzed by agarose gel electrophoresis. All primers used are listed in Table 3 .
RNA isolation and quantitative RT-PCR of mRNA
Total RNA of EVs or cells was extracted using TRIzol Reagent (Life Technologies Co.). Residual DNA was removed by DNase I digestion following RNA isolation, as described below. The following reagents were mixed in an RNase-free microcentrifuge tube: 1 mg RNA, 1 ml 10 × DNase buffer (500 mM Tris -HCl, pH 8.0, 50 mM MgCl 2 , 10 mM DTT), 1 ml of 1 Kunitz units/ml RNase-free DNase I (Sigma) in a volume up to 10 ml with RNase-free water, and then incubated for 30 min at 378C to remove contaminating gDNA. One microliter of 2.5 mM EDTA was added into the tubes containing the EVs, and incubated for 5 min at 658C to inactivate the DNase. The mixture of 11 ml purified RNA and 1 ml of 25 pmol/ml randomized primer (Toyobo Co.) was denatured by boiling at 658C for 5 min, followed by immediate cooling on ice. Twelve microliters of denatured RNA, 4 ml of 5× RT buffer (Toyobo), 2 ml dNTP mixture (10 mM each of dNTPs, Toyobo), 1 ml of 10 U/ml RNase inhibitor (Toyobo), and 1 ml ReverTre Acew (a reverse transcriptase) (Toyobo) were mixed to a total volume of 20 ml transcriptase reagents. The mixture was incubated at 308C for 10 min, 428C for 30 min, 858C for 5 min, and 48C for 5 min to allow for the synthesis of first-strand complimentary DNA (cDNA). Subsequently, real-time quantification of cDNA was performed using SYBRw premix Ex Taq TM II (TaKaRa) by the CFX96 TM Real-Time PCR Detection System as described above. Additionally, absolute quantitative RT-PCR of BCR/ABL mRNA was performed with BCR/ABL mRNA detection kit (Shanghai Shenyou Co. Ltd.).
Cell isolation and culture
VSMCs, isolated from human mesenteric arteries, were characterized by smooth muscle cell morphology (multilayer sheets, 'hills and valleys') and expression of smooth muscle a-actin by immunostaining with a specific a-actin monoclonal antibody (Li et al., 2008) . K562 and HEK293 cells were obtained from the American Type Culture Collection (ATCC; Manassas, VA, USA). HEK293 cells were transfected with human AT 1 receptor using EGFP expression vector pEGFP-N1 to generate monoclonal HEK293 cells that include AT 1 -EGFP DNA and stably express AT 1 receptors (AT 1 -HEK293 cells). These cells were cultured at 378C in 95% air/5% CO 2 atmosphere in Dulbecco's Modified Eagle's Medium (DMEM, Gibco, Life Technologies), supplemented with 10% fetal bovine serum (Gibco, Life Technologies). AT 1 -HEK293 cells were selected by adding 200 mg/ml of G418 into the culture medium.
Immunoblotting
The antibodies used in our experiments included: monoclonal mouse anti-human CD63 antibody (Abcam PLC.), monoclonal rat anti-human AGO2 antibody (Sigma-Aldrich), polyclonal rabbit anti-human AT 1 receptor antibody (Santa Cruz Biotechnology, Inc.), polyclonal rabbit anti-human or rat c-ABL (BCR-ABL) antibody (Cell Signaling Technology, Inc.), polyclonal mouse antihuman b-actin antibody (Santa Cruz Biotechnology), and polyclonal rabbit anti-human actin antibody (Sigma-Aldrich). Immunoblotting was performed as previously reported except that the transblots were probed with the antibodies against CD63 (1:500) (for experiments visualizing CD63, the samples were run under non-reducing conditions; Ashiru et al., 2010) , AGO2 (1:2000) (Zhang et al., 2010) , AT 1 receptor (1:600) (Zeng et al., 2003 (Zeng et al., , 2006 , TSG101 (1:400), flotillin-1 (1:400), HSP70 (1:400), c-ABL (BCR/ABL) antibody (1:1000) (Pluk et al., 2002) , b-actin (1:600), or anti-actin antibody (1:400). Proteins were visualized using the enhanced chemiluminescence system. Normalization was performed by blotting the same samples with an antibody against b-actin. Dual-color fluorescent in situ hybridization BCR/ABL D-FISH was performed using a kit according to the manufacturer's recommendation (Beijing GP Medical Technologies, Ltd.). Two-color directly labeled translocation probes were used for the detection of BCR, ABL, and BCR/ABL hybrid gene. Neutrophils isolated from peripheral blood of healthy humans with human-neutrophil separating medium (TBD Co. Ltd.) were exposed to K562 EVs (1 × 10 5 /ml culture medium, 24 h). To evaluate the levels of BCR/ABL hybrid gene, Philadelphia (Ph) chromosome-positive neutrophils were counted among 200 cells using a fluorescence microscope (Pelz et al., 2002) .
Statistical analysis
The data are expressed as mean + SD. Comparison within groups was made by analysis of variance (ANOVA) for repeated measures, and comparison among groups was made by factorial ANOVA and Duncan's test (t test when only two groups were compared). A value of P , 0.05 was considered significant.
